The DRD2 gene myoclonic dystonia DRD2 related genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DRD2 gene, which are linked to the development of myoclonic dystonia. Myoclonic dystonia is a neurological movement disorder characterized by quick, involuntary muscle contractions (myoclonus) and prolonged muscle contractions (dystonia) that result in twisting and repetitive movements or abnormal postures. The DRD2 gene plays a crucial role in the dopamine signaling pathway, which is essential for controlling movement, emotional response, and pain processing in the brain. Mutations in the DRD2 gene can disrupt this pathway, leading to the symptoms associated with myoclonic dystonia.
The test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. It involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic alterations in the DRD2 gene that might be responsible for the condition. This test is crucial for individuals experiencing symptoms of myoclonic dystonia or those with a family history of the disorder, as it can provide a definitive diagnosis and guide treatment options.
The cost of the DRD2 gene myoclonic dystonia DRD2 related genetic test at DNA Labs UAE is 4400 AED. Although the price may seem high, the test offers invaluable insights into the genetic basis of the disorder, enabling targeted interventions and potentially improving the quality of life for those affected by myoclonic dystonia.
The EPM2A gene myoclonic epilepsy of Lafora genetic test is a specialized diagnostic procedure designed to identify mutations in the EPM2A gene, which are known to cause Lafora disease. Lafora disease is a rare, autosomal recessive disorder characterized by the presence of Lafora bodies (abnormal glycogen inclusions) within cells, leading to progressive myoclonus epilepsy. This condition typically manifests in late childhood or adolescence, resulting in seizures, muscle spasms, and neurological decline.
The test is crucial for early diagnosis and management of the condition, enabling healthcare providers to tailor treatment plans that can potentially slow the disease's progression and improve the quality of life for affected individuals. It involves collecting a DNA sample, usually through a blood draw, which is then analyzed in the laboratory for specific mutations in the EPM2A gene.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test for EPM2A gene myoclonic epilepsy of Lafora is priced at 4400 AED. The laboratory is equipped with advanced technology and staffed by experts in genetic diagnostics, ensuring high accuracy and reliability of the test results. Opting for this test at DNA Labs UAE provides patients and their families with crucial information for managing Lafora disease, supported by the lab's commitment to excellence in genetic analysis and customer care.
The NHLRC1 Gene Myoclonic Epilepsy of Lafora Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the NHLRC1 gene, which are linked to Lafora disease, a rare and severe form of myoclonic epilepsy. Lafora disease is characterized by the accumulation of Lafora bodies within cells, leading to progressive neurological deterioration that typically begins in late childhood or adolescence. Symptoms include myoclonus, seizures, and cognitive decline, among others.
The test, priced at 4400 AED, involves analyzing the patient's DNA to identify specific genetic alterations in the NHLRC1 gene that are known to cause Lafora disease. This genetic insight is crucial for confirming a diagnosis, understanding the disease's progression, and potentially guiding treatment decisions. The procedure is carried out in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results. Identifying carriers of the mutation can also provide valuable information for family planning purposes, as Lafora disease is inherited in an autosomal recessive pattern.
The "NOL3 Gene Myoclonus Familial Cortical Genetic Test" is a specialized diagnostic tool designed to identify mutations in the NOL3 gene, which have been linked to familial cortical myoclonus. Familial cortical myoclonus is a rare neurological disorder characterized by quick, involuntary muscle jerks originating from the cerebral cortex, often inherited in an autosomal dominant pattern. Mutations in the NOL3 gene disrupt normal brain function, leading to these characteristic symptoms.
This genetic test involves analyzing the patient's DNA to look for specific mutations in the NOL3 gene that are known to cause the condition. Identifying these mutations can confirm a diagnosis of familial cortical myoclonus, which is crucial for managing the condition effectively. Early diagnosis can help in tailoring treatment plans that may include medications, lifestyle adjustments, and monitoring for potential complications.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. DNA Labs UAE provides comprehensive support throughout the testing process, from sample collection to result interpretation, ensuring that patients and their families receive the information and guidance they need to manage the condition effectively.
The LPIN1 gene plays a crucial role in lipid metabolism within the body. Mutations in this gene can lead to a condition known as acute recurrent myoglobinuria, which is characterized by repeated episodes of muscle pain, weakness, and the release of myoglobin into the urine. This condition can lead to serious complications, including kidney damage, if not diagnosed and managed properly.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the LPIN1 gene that are associated with acute recurrent myoglobinuria. This test is crucial for individuals who have experienced symptoms of the condition or have a family history of similar symptoms. Early detection through this genetic test can facilitate timely management and intervention strategies to prevent complications.
The cost of the LPIN1 Gene Myoglobinuria Acute Recurrent Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable tool for healthcare providers in diagnosing this rare but potentially severe condition, allowing for personalized treatment plans based on the genetic makeup of the individual.
The "ITGA7 Gene Myopathy Due to Integrin 7A Deficiency Genetic Test" is a specialized diagnostic examination aimed at identifying mutations in the ITGA7 gene, which can lead to a rare form of myopathy. Myopathy associated with ITGA7 gene mutations is characterized by muscle weakness and reduced muscle mass due to a deficiency in integrin alpha-7, a protein essential for muscle cell structure and function. This condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.
The test is performed at DNA Labs UAE, a leading facility in genetic diagnostics and research. The procedure involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the ITGA7 gene that are known to cause the condition. This genetic test is crucial for accurate diagnosis, allowing for appropriate management and treatment plans to be developed for affected individuals.
The cost of the ITGA7 Gene Myopathy Due to Integrin 7A Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This cost covers the genetic analysis and a comprehensive report that details the findings. For patients suspected of having this rare form of myopathy, or for those with a family history of the condition, this test provides a valuable tool for confirming the diagnosis and facilitating early intervention strategies.
The AMPD1 gene is pivotal in encoding the enzyme myoadenylate deaminase, which plays a crucial role in muscle metabolism, particularly during strenuous exercise. A deficiency in this enzyme, due to mutations in the AMPD1 gene, can lead to a condition known as myoadenylate deaminase deficiency. This condition is characterized by muscle pain, cramps, and exercise intolerance, making it crucial for individuals experiencing such symptoms to undergo diagnostic testing.
DNA Labs UAE offers a specialized genetic test aimed at diagnosing myoadenylate deaminase deficiency by analyzing the AMPD1 gene for any mutations that could lead to the condition. The test involves collecting a DNA sample from the patient, which is then examined for specific mutations in the AMPD1 gene known to cause the deficiency.
The cost of this genetic test at DNA Labs UAE is 4400 AED. This investment allows for a comprehensive understanding of the individual's genetic predisposition to myoadenylate deaminase deficiency, enabling targeted management and treatment strategies. It's an essential tool for individuals experiencing unexplained muscle fatigue and pain, offering a pathway to a more informed and personalized healthcare approach.
The MICU1 Gene Myopathy with Extrapyramidal Signs Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the MICU1 gene, which are implicated in a rare genetic disorder characterized by muscle weakness (myopathy) and abnormalities in movement control (extrapyramidal signs). This condition falls under a broader category of mitochondrial diseases, given MICU1's role in calcium uptake regulation within the mitochondria, essential for energy production and muscle function.
Priced at 4400 AED, this test offers a critical pathway for individuals exhibiting symptoms related to this disorder to obtain a definitive diagnosis. Through a simple genetic analysis, it enables healthcare providers to tailor treatment plans more effectively, potentially improving the quality of life for affected individuals. The test represents a significant advancement in the field of genetic diagnostics, offering hope and answers to patients and their families navigating the complexities of rare genetic conditions.
The CHKB Gene Muscular Dystrophy Congenital Megaconial Type Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CHKB gene, which are linked to a rare form of muscular dystrophy known as congenital megaconial type. This condition is characterized by muscle weakness, developmental delays, and distinctive enlarged mitochondria (megaconia) in muscle cells, leading to a range of physical and possibly cognitive impairments.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing techniques. By examining the specific genetic makeup of the CHKB gene, specialists can confirm a diagnosis of congenital megaconial muscular dystrophy, allowing for early intervention, personalized treatment plans, and genetic counseling for families.
Given the complexity and rarity of this condition, the CHKB gene test is a crucial resource for individuals exhibiting symptoms or with a family history of muscular dystrophy, providing them with essential information for managing the disease. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing results, contributing significantly to the understanding and treatment of this genetic disorder.
The "DMD Gene Muscular Dystrophy Duchenne Type Genetic Test" is a specialized diagnostic procedure aimed at detecting mutations in the DMD gene, which is responsible for Duchenne Muscular Dystrophy (DMD). This condition is a severe form of muscular dystrophy that primarily affects boys, leading to muscle weakness and degeneration over time. Early diagnosis through genetic testing can provide valuable information for managing the condition, enabling timely interventions and support.
The test is conducted at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. By analyzing a sample of the patient's DNA, the test identifies specific mutations in the DMD gene that are indicative of Duchenne Muscular Dystrophy. This process involves sophisticated technology and expertise to ensure accurate results.
The cost of the DMD Gene Muscular Dystrophy Duchenne Type Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the intricate nature of genetic testing and the specialized analysis required to pinpoint mutations associated with the condition. While the cost may seem significant, the value of the information gained from this test is immeasurable for affected families, providing them with a clear diagnosis and guiding treatment and management decisions for Duchenne Muscular Dystrophy.
